Locations
Palo Alto, CA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
1 - 10 employees
Stage
Series A
founded in
2014
Auransa is a clinical stage, AI-native biopharma that utilizes a proprietary AI platform to mine extensive human disease data for discovering novel therapeutics, particularly in cancer care. The company is advancing its drug pipeline with a focus on liver cancer and heart-safe chemotherapy, leveraging collaborations with leading pharmaceutical companies and academic institutions to enhance drug discovery and development. With a strong leadership team experienced in drug development, Auransa aims to raise the standard of cancer care through innovative therapies tailored for responsive patient populations.
Something looks off?